IMPACT OF VASCULAR CLOSURE WITH THE PRE-CLOSURE TECHNIQUE ON ADVERSE EVENTS IN PATIENTS UNDERGOING TRANSFEMORAL BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER registry  by O&apos et al.
ACC-i2 with TCT
E234
JACC March 27, 2012
Volume 59, Issue 13
IMPACT OF VASCULAR CLOSURE WITH THE PRE-CLOSURE TECHNIQUE ON ADVERSE EVENTS IN 
PATIENTS UNDERGOING TRANSFEMORAL BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 
2-CENTER REGISTRY
i2 Poster Contributions
McCormick Place South, Hall A
Saturday, March 24, 2012, 9:30 a.m.-Noon
Session Title: Outcomes in Patients Treated with TAVR
Abstract Category: 20. PCI - Valvular Heart Disease
Presentation Number: 2533-319
Authors: Brian P. O’Neill, Vikas Singh, Jennifer Yu, David Knopf, Usman Baber, Claudia Martinez, Carlos Alfonso, Jason Kovacic, George Dangas, Evan 
Jacobs, Annapoorna Kini, Roxana Mehran, Samin Sharma, Pedro Martinez-Clark, Samantha Sartori, Alan Heldman, William O’Neill, Mauricio Cohen, 
University of Miami Miller School of Medicine, Miami, FL, USA, Mount Sinai Medical Center, New York, NY, USA
Background: Ischemic and bleeding complications, or net adverse clinical events (NACE), are common following transfemoral balloon aortic 
valvuloplasty (BAV). The impact of suture-mediated vascular closure on NACE in this setting is not known.
Methods: We conducted a retrospective review of 428 consecutive patients who underwent BAV with large sheaths (10-13 French) over a 6-year 
period at two high-volume academic centers. Vascular closure was performed using the ProGlide (Abbott Vascular) device. NACE was defined as the 
composite of major bleeding and major adverse clinical events (MACE). All events were adjudicated by an independent CEC who were blinded to 
antithrombin use.
Results: Pre-closure was performed in 269 (62.8%) of patients. While bivalirudin was used more frequently in those with pre-closure (60.6% vs. 
37.7%, p<0.001), a history of prior BAV (11.1% vs. 3.6%, p=0.04) and peripheral vascular disease (30.7% vs. 19.7%, p=0.01) was more common in 
those not undergoing pre-closure (n=159, 37%). Other clinical and demographic features were well balanced between groups. Vascular closure was 
associated with a significant reduction in NACE (Figure). Results remained significant after adjusting for baseline differences and bivalirudin use (OR 
0.38, 95% CI: 0.21 - 0.68; p=0.001).
Conclusions: Our study suggests that suture-mediated vascular closure results in a substantial reduction in NACE after transfemoral BAV. Large 
randomized clinical trials should be conducted to confirm our results.
 
